BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31990410)

  • 21. Distribution of protoporphyrin IX in erythrocytes in a case of acquired erythropoietic protoporphyria.
    Heerfordt IM; Fontenete S; Lerche CM; Wulf HC
    Photodiagnosis Photodyn Ther; 2022 Mar; 37():102629. PubMed ID: 34798346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria.
    Mirmiran A; Schmitt C; Lefebvre T; Manceau H; Daher R; Oustric V; Poli A; Lacapère JJ; Moulouel B; Puy H; Karim Z; Peoc'h K; Lenglet H; Simonin S; Deybach JC; Nicolas G; Gouya L
    Am J Hum Genet; 2019 Feb; 104(2):341-347. PubMed ID: 30712775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of murine erythropoietic protoporphyria-associated skin photosensitivity and liver disease by dermal and hepatic ferrochelatase.
    Pawliuk R; Tighe R; Wise RJ; Mathews-Roth MM; Leboulch P
    J Invest Dermatol; 2005 Jan; 124(1):256-62. PubMed ID: 15654982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversion of hepatobiliary alterations By bone marrow transplantation in a murine model of erythropoietic protoporphyria.
    Fontanellas A; Mazurier F; Landry M; Taine L; Morel C; Larou M; Daniel JY; Montagutelli X; de Salamanca RE; de Verneuil H
    Hepatology; 2000 Jul; 32(1):73-81. PubMed ID: 10869291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members.
    Berroeta L; Man I; Goudie DR; Whatley SD; Elder GH; Ibbotson SH
    Br J Dermatol; 2007 Nov; 157(5):1030-1. PubMed ID: 17711525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incomplete erythropoietic protoporphyria caused by a splice site modulator homozygous IVS3-48C polymorphism in the ferrochelatase gene.
    Mizawa M; Makino T; Nakano H; Sawamura D; Shimizu T
    Br J Dermatol; 2016 Jan; 174(1):172-5. PubMed ID: 26280465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recognized and Emerging Features of Erythropoietic and X-Linked Protoporphyria.
    Di Pierro E; Granata F; De Canio M; Rossi M; Ricci A; Marcacci M; De Luca G; Sarno L; Barbieri L; Ventura P; Graziadei G
    Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietic Protoporphyria and X-Linked Protoporphyria: pathophysiology, genetics, clinical manifestations, and management.
    Balwani M
    Mol Genet Metab; 2019 Nov; 128(3):298-303. PubMed ID: 30704898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New insights into the pathogenesis of erythropoietic protoporphyria and their impact on patient care.
    Schneider-Yin X; Gouya L; Meier-Weinand A; Deybach JC; Minder EI
    Eur J Pediatr; 2000 Oct; 159(10):719-25. PubMed ID: 11039124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homeostasis of iron and hepcidin in erythropoietic protoporphyria.
    Bossi K; Lee J; Schmeltzer P; Holburton E; Groseclose G; Besur S; Hwang S; Bonkovsky HL
    Eur J Clin Invest; 2015 Oct; 45(10):1032-41. PubMed ID: 26199063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seasonal palmar keratoderma in erythropoietic protoporphyria indicates autosomal recessive inheritance.
    Holme SA; Whatley SD; Roberts AG; Anstey AV; Elder GH; Ead RD; Stewart MF; Farr PM; Lewis HM; Davies N; White MI; Ackroyd RS; Badminton MN
    J Invest Dermatol; 2009 Mar; 129(3):599-605. PubMed ID: 18787536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythropoietic Protoporphyria in a Japanese Population.
    Mizawa M; Makino T; Nakano H; Sawamura D; Shimizu T
    Acta Derm Venereol; 2019 Jun; 99(7):634-639. PubMed ID: 30938825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivation of protoporphyrin IX in erythrocytes in patients with erythropoietic protoporphyria: A new treatment modality.
    Wulf HC; Nissen CV; Philipsen PA
    Photodiagnosis Photodyn Ther; 2020 Mar; 29():101582. PubMed ID: 31809913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked Protoporphyria.
    Balwani M; Naik H; Anderson KE; Bissell DM; Bloomer J; Bonkovsky HL; Phillips JD; Overbey JR; Wang B; Singal AK; Liu LU; Desnick RJ
    JAMA Dermatol; 2017 Aug; 153(8):789-796. PubMed ID: 28614581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mouse model provides evidence that genetic background modulates anemia and liver injury in erythropoietic protoporphyria.
    Abitbol M; Bernex F; Puy H; Jouault H; Deybach JC; Guénet JL; Montagutelli X
    Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1208-16. PubMed ID: 15677551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultraviolet A phototest positivity is associated with higher free erythrocyte protoporphyrin IX concentration and lower transferrin saturation values in erythropoietic protoporphyria.
    Genovese G; Maronese CA; Moltrasio C; Piccinno R; Marletta DA; De Luca G; Graziadei G; Granata F; Di Pierro E; Cappellini MD; Marzano AV
    Photodermatol Photoimmunol Photomed; 2022 Mar; 38(2):141-149. PubMed ID: 34420239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repurposing of glycine transport inhibitors for the treatment of erythropoietic protoporphyria.
    Halloy F; Iyer PS; Ghidini A; Lysenko V; Barman-Aksözen J; Grubenmann CP; Jucker J; Wildner-Verhey van Wijk N; Ruepp MD; Minder EI; Minder AE; Schneider-Yin X; Theocharides APA; Schümperli D; Hall J
    Cell Chem Biol; 2021 Aug; 28(8):1221-1234.e6. PubMed ID: 33756123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of Patients With Erythropoietic Protoporphyria-Related Progressive Liver Disease.
    Ardalan ZS; Chandran S; Vasudevan A; Angus PW; Grigg A; He S; Macdonald GA; Strasser SI; Tate CJ; Kennedy GA; Testro AG; Gow PJ
    Liver Transpl; 2019 Nov; 25(11):1620-1633. PubMed ID: 31469227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver disease and erythropoietic protoporphyria: a concise review.
    Casanova-González MJ; Trapero-Marugán M; Jones EA; Moreno-Otero R
    World J Gastroenterol; 2010 Sep; 16(36):4526-31. PubMed ID: 20857522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNAi-mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of β-thalassemia intermedia.
    Schmidt PJ; Liu K; Visner G; Fitzgerald K; Fishman S; Racie T; Hettinger JL; Butler JS; Fleming MD
    Am J Hematol; 2018 Jun; 93(6):745-750. PubMed ID: 29498084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.